<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0248103.ref085">
 <label>85</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Caruso</surname>
   <given-names>JA</given-names>
  </name>, 
  <name>
   <surname>Karakas</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Zhang</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Yi</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Albarracin</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Sahin</surname>
   <given-names>A</given-names>
  </name>, 
  <etal>et al</etal>. 
  <article-title>Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence</article-title>. 
  <source>Breast Cancer Res</source>. 
  <year>2014</year>; 
  <volume>16</volume>(
  <issue>6</issue>): 
  <fpage>3417</fpage>. 
  <pub-id pub-id-type="doi">10.1186/s13058-014-0497-4</pub-id>
  <?supplied-pmid 25551582?>
  <pub-id pub-id-type="pmid">25551582</pub-id>
 </mixed-citation>
</ref>
